A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Diabetes and ASCVD Risk Panel with Scores
Test Code92062
CPT Codes
82947, 83036, 80061
Includes
Glucose
Hemoglobin A1c
Total Cholesterol, HDL Cholesterol, Triglycerides, Non-HDL and Calculated Components
Risks and Personal Factors
If Triglyceride is >400 mg/dL, then Direct LDL will be performed at an additional charge (CPT code(s): 83721).
Hemoglobin A1c
Total Cholesterol, HDL Cholesterol, Triglycerides, Non-HDL and Calculated Components
Risks and Personal Factors
If Triglyceride is >400 mg/dL, then Direct LDL will be performed at an additional charge (CPT code(s): 83721).
Preferred Specimen
4 mL serum collected in a Serum Separator Tube (SST®) and 1 mL whole blood collected in an EDTA (lavender-top) tube
Patient Preparation
If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.
Minimum Volume
2 mL serum • 0.5 mL whole blood
Instructions
For risk calculations to be performed, the following patient-specific information must be provided at the time of order:
Age: Years
Gender: M (for male) or F (for female)
Race - African American: Y (for yes) or N (for no)
Systolic Blood Pressure: mmHg
Treatment for High B.P.: Y (for yes) or N (for no)
Diabetes Status: Y (for yes) or N (for no)
Smoking Status: Y (for yes) or N (for no)
Age: Years
Gender: M (for male) or F (for female)
Race - African American: Y (for yes) or N (for no)
Systolic Blood Pressure: mmHg
Treatment for High B.P.: Y (for yes) or N (for no)
Diabetes Status: Y (for yes) or N (for no)
Smoking Status: Y (for yes) or N (for no)
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Serum
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 28 days
Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 28 days
Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
See individual tests • Sodium fluoride/oxalate (grey-top) tube • Heparinized plasma
Methodology
Enzymatic • Spectrophotometry (SP)
Setup Schedule
Sets up 5 days a week.
Clinical Significance
To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.